wk 6- ADR Flashcards
types of adverse reactions
type A- augumented reactions
type B- hypersensitivity/bizzare
type C- chronic
type. D- delayed
type E - end of use
top 4 meds associated with Es
opioids
nsaids
aspirin
beta blockers
define ADR
any reaction to a drug that is harmful to a patient
things that contribute to ADRs (outside of patient factors)
-failing of clinical trials- not enough subjects to detect ADRs until in population
-medication errors (at the level of prescribing, dispensing, taking, adherence, monitoring)
-small therapeutic window
examples of low therapeutic index drugs
anticoagulants
insulin
cardiac glycosides
antiarrhythmics
TCA
anti cancer
immunosuppressants
ED50
effective dose required to produce 50% of max desired effect
LD50
lethal dose required to kill 50% of animals that receive it
What predisposes people to a TYPE A ADR
- very young or old- metabolism and excretion not as efficient
- distribution - affected by changes in body comp and availability of plasma protein for binding
- disease - liver, kidney, GI motility, plasma protein concentrations
- genetics- differences in enzyme activity which changes how the drugs are metabolised
- drug to drug interactions
- one drug can increase or decrease the other
- drugs that have opposite actions can cancel eachother out
- drugs with same actions can potentiate one another
type B ADRs
-rare but unpredictable and not dose related
can be due to allergy or other causes
type B - idiosyncrasy
an effect unrelated to the action of the drug
type B - insensitivity and intolerance
outliers that respond differently to the vast majority
hypersensitivity reactions
immunological reaction to drugs
type 1 -
- type 4 hypersensitvity reactions
type 1 hypersensitvity reaction
anaphylaxis
allergen- IgE
antibodies attach to mast cells - release mediators (eg histamine)
local effects- hayfever, asthma, urticaria
systemic effects- swelling/anaphylaxis
occurs, minutes to hours after exposure
type 2
cytotoxic reaction
drug bind to blood cell membranes
IgG and IgM antibodies activate complement system and autolysis of RBCS
type 3 hypersensitivity reaction
immune complex reaction
drugs for immune complexes with antibodies which circulate in blood and can be deposited in particular areas of the body
occurs 1-3 weeks after exposure
type 4 hypersensitvity
drugs combine with proteins in the skin to form antigen
t cells activitated and cause damage to skin cells (rashes, lumps, itchy, weeping)
occurs 2-7 days after drug exposure
teratogenesis
drugs causing abnormal foetal development
carcinogenesis
drug induced tumours